Ionis Pharmaceuticals Inc. buy marge
Start price
21.06.15
/
50%
€54.86
Target price
24.05.16
€70.00
Performance (%)
-45.15%
End price
24.05.16
€30.09
Summary
This prediction ended on 24.05.16 with a price of €30.09. Massive losses of -45.15% were the result for the BUY prediction by marge. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 3.191% | 3.191% | 105.260% | 87.207% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% | 61.619% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% | 100.420% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% | 50.705% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% | 63.730% |
Comments by marge for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Isis Pharmaceuticals
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)